enVVeno Medical (NASDAQ:NVNO - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.30) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.05, Zacks reports.
enVVeno Medical Stock Performance
Shares of NVNO stock traded up $0.09 during trading hours on Wednesday, reaching $3.10. The company had a trading volume of 32,590 shares, compared to its average volume of 109,471. The company has a market capitalization of $54.36 million, a P/E ratio of -2.40 and a beta of 1.38. enVVeno Medical has a twelve month low of $2.45 and a twelve month high of $6.83. The stock's fifty day simple moving average is $3.29 and its 200 day simple moving average is $3.64.
enVVeno Medical Company Profile
(
Get Free Report)
enVVeno Medical Corporation Nasdaq: NVNO is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Featured Articles
Before you consider enVVeno Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and enVVeno Medical wasn't on the list.
While enVVeno Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
